Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
8,612,876
-
Shares change
-
+809,848
-
Total reported value, excl. options
-
$193,764,181
-
Value change
-
+$18,675,960
-
Put/Call ratio
-
443%
-
Number of buys
-
33
-
Number of sells
-
-32
-
Price
-
$22.50
Significant Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q1 2015
88 filings reported holding AXDX - Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share as of Q1 2015.
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,612,876 shares
of 27,795,576 outstanding shares and own 31% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (2,067,560 shares), VANGUARD GROUP INC (825,832 shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (768,000 shares), Miura Global Management, LLC (600,000 shares), BlackRock Fund Advisors (582,936 shares), BlackRock Institutional Trust Company, N.A. (420,869 shares), STATE STREET CORP (350,740 shares), OBERMEYER WOOD INVESTMENT COUNSEL, LLLP (278,049 shares), NORTHERN TRUST CORP (254,353 shares), and Iguana Healthcare Management, LLC (250,000 shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.